Delivery Order 75N95025D00005-75N95026F00001

This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...

This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...

This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The $2,499,626.17 contract is for the NIDA Center for Genetic Studies, providing services such as receiving, processing, storing, and distributing de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023...

Rutgers, The State University has been awarded a task order against an existing National Institute on Drug Abuse (NIDA) indefinite delivery contract to establish and operate the NIDA Center for Genetic Studies. The task order, valued at $2,716,366, provides continued genetic research services for the Center between March 2023 and March 2024. Specifically, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants...

The National Institute on Drug Abuse (NIDA) Center for Genetic Studies awarded a $2.5 million firm fixed price delivery order contract to Rutgers, The State University Research Financial Services Division for the period of March 14, 2022 through March 13, 2023. As the prime contractor, Rutgers, The State University Research Financial Services Division will provide research services in support of NIDA's Center for Genetic Studies, with performance taking place in New Brunswick, New Jersey.

This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University to establish and operate the NIDA Center for Genetic Studies. The contract is a single-award Indefinite Delivery Contract valued at $2,144,869.96 to support the continued genetic research services for the Center between September 2019 and September 2022, with a potential extension through March 2028. The contract is not designated as a set-aside. As the...

This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract is for the NIDA Center for Genetic Studies, with a period of performance from March 14, 2020 to March 13, 2021 and a ceiling value of $2,499,999.99. The contract was awarded as a Firm Fixed Price task order under a larger Indefinite Delivery Contract (IDC) that Rutgers holds with NIDA, which has...

The National Institute on Drug Abuse (NIDA) awarded a $25K purchase order to Transnetyx, Inc. for automated genotyping services to support the Neuronal Ensembles in Drug Addiction Section's research examining behavioral and cellular mechanisms of learning in addiction. This firm fixed-price contract, awarded December 30, 2025, with completion targeted for December 29, 2026, requires genotyping analysis performed at Transnetyx's Baltimore, Maryland location. The award carries no set-aside...

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, awarded a delivery order valued at $1.96 million to Research Triangle Institute (RTI International) for the synthesis and distribution of drugs of abuse and related compounds. This task order (TO8, N01DA-22-8944) runs from June 9, 2025 through June 8, 2026, with an ultimate completion date of June 8, 2027, and utilizes a cost-plus-fixed-fee pricing structure with no set-aside designation. The work will...

This contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (HHS-NIH-NIDA) to Research Triangle Institute - doing business as R T I International is for the synthesis and distribution of drugs of abuse and related compounds from June 9, 2023 to June 8, 2024 under Task Order 75N95023F00001 (TO4) of major program N01DA-22-8944. The contract type is a delivery order with a place of performance in Research Triangle Park, North...